Neurological and neuromuscular disease.
D000328:Adult; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D009157:Myasthenia Gravis / Q000628:therapy; D009422:Nervous System Diseases / Q000628:therapy*; D009468:Neuromuscular Diseases / Q000150:complications / Q000628:therapy*; D011129:Polyradiculoneuropathy / Q000150:complications / Q000628:therapy; D012119:Respiration; D012121:Respiration, Artificial; D012131:Respiratory Insufficiency / Q000209:etiology / Q000628:therapy; D013934:Thymectomy
D002800:Cholinesterase Inhibitors; D007166:Immunosuppressive Agents